𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical efficacy of WT1 peptide vaccination in patients with acute myelogenous leukemia and myelodysplastic syndrome

✍ Scribed by Masaki Yasukawa; Hiroshi Fujiwara; Toshiki Ochi; Koichiro Suemori; Hiroshi Narumi; Taichi Azuma; Kiyotaka Kuzushima


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
289 KB
Volume
84
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Fusion of TEL/ETV6 to a novel ACS2 in my
✍ Fumiharu Yagasaki; Itsuro Jinnai; Satoru Yoshida; Yasuko Yokoyama; Akira Matsuda πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 496 KB πŸ‘ 1 views

We identified a novel human long fatty acyl CoA synthetase 2 gene, ACS2, as a new ETV6 fusion partner gene in a recurrent t(5;12)(q31;p13) translocation in a patient with refractory anemia with excess blasts (RAEB) with basophilia, a patient with acute myelogenous leukemia (AML) with eosinophilia, a

Amplification of the MLL gene on double
✍ Berthold Streubel; Peter Valent; Ulrich JΓ€ger; Martin EdelhΓ€user; Hannes Wandt; πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 184 KB πŸ‘ 1 views

Gene amplification is one of the mechanisms for activating proto-oncogenes resulting in an enhanced expression of the corresponding gene product. By fluorescence in situ hybridization (FISH), amplification of the proto-oncogene MLL has been described only in seven patients with acute myeloid leukemi

Concurrent translocations of MLL and CBF
✍ Susan Mathew; David Head; Jeffrey E. Rubnitz; Susana C. Raimondi πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 257 KB πŸ‘ 2 views

The MLL gene at 11q23 is frequently disrupted by chromosomal translocations in de novo acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL), and in secondary leukemia induced by treatment with inhibitors of topoisomerase II, including the epipodophylotoxins. The CBFA2 gene at 21q22 is also